Muzaffar Qazilbash

52PUBLICATIONS
156CO-AUTHORS
AnaesthesiologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (52)

|Dec 05, 2025
Results of delayed or salvage autologous hematopoietic stem cell transplantation for multiple myeloma.

Oren Pasvolsky, Curtis Marcoux, Denái R Milton

|Oct 27, 2025
CD70-Targeting CAR NK Cells Overcome BCMA Downregulation and Improve Survival in High-risk Multiple Myeloma Models.

Paul Lin, Sunil Acharya, Francia Reyes-Silva

|Aug 25, 2025
High-Dose Chemotherapy for Multiply or Poor-Risk Relapsed Germ Cell Tumors.

Yago Nieto, John F Ward, Wayne Hofstetter

|Apr 11, 2025
The Impact of Melphalan Conditioning and CD34 + Cell Dose and Schedule on Post-Transplant Outcomes in AL Amyloidosis.

Eli Muchtar, Vaishali Sanchorawala, Hamza Hassan

|Mar 30, 2025
Outcomes of patients with multiple myeloma undergoing autologous transplant with suboptimal pretransplant response.

Oren Pasvolsky, Muhammad Bilal Abid, Denái R Milton

Pageof 9